4289.0
Naloxone use in overdose prevention: new approaches and policies
Naloxone use in overdose prevention: new approaches and policies
Tuesday, November 3, 2015: 2:30 p.m. - 4:00 p.m.
Oral
This session aims to explore the use of naloxone by emergency medical responders as well as lay administrators, such as peers and family members, to prevent opioid overdose mortality. Targeted overdose prevention training and the distribution of overdose prevention kits that include intranasal naloxone may be an effective strategy to reduce overdose mortality. Additionally, it is crucial that interventions are responsive to gender, culture, and environment. Some state-level naloxone access policies include third party prescribing, standing order prescriptions, and prescriber immunity. Continued evaluation of the design and implementation of naloxone-related strategies are needed to enhance opioid overdose prevention.
Session Objectives: Describe factors related to preventing opiate overdose mortality.
Identify the indications and contraindications for intranasal naloxone usage.
Describe a new mode of naloxone distribution to an at risk population.
Describe the impact of state naloxone access policies on pharmaceutical opioid and heroin mortality.
Moderator:
Bridget Rogala, MPH, MCHES
2:30pm
2:50pm
3:10pm
3:30pm
See individual abstracts for presenting author's disclosure statement and author's information.
Organized by: Alcohol, Tobacco, and Other Drugs
Endorsed by: Aging & Public Health, Law, Injury Control and Emergency Health Services, Medical Care Section, Black Caucus of Health Workers
CE Credits: Medical (CME), Health Education (CHES), Nursing (CNE), Public Health (CPH) , Masters Certified Health Education Specialist (MCHES)
See more of: Alcohol, Tobacco, and Other Drugs